|New Members Appointed to National Neurology Advisory Council
U.S. Department of Health and Human Services Secretary Michael O. Leavitt today
announced three new appointments and one reappointment to the National Advisory
Neurological Disorders and Stroke Council, the major advisory panel of the National
Institute of Neurological Disorders and Stroke (NINDS). The NINDS, a component
of the National Institutes of Health (NIH), is the nationís primary supporter
of basic, translational, and clinical research on the brain and nervous system.
NINDS Director Story Landis, Ph.D., will introduce the new members, who will
serve through July 2009, at the Councilís September 15, 2005 meeting.
The National Advisory Neurological Disorders and Stroke Council meets three
times each year to review applications from scientists seeking financial support
for biomedical research and research training on disorders of the brain and nervous
system. Members also advise the Institute on research program planning and priorities.
The 18-member Council is composed of physicians, scientists, and representatives
of the public. The new members are:
Robi Blumenstein, President, MRSSI, Inc.
MRSSI, Inc. provides consulting and grant-making services to foundations involved
in researching Huntington's disease. Mr. Blumenstein was a principal and co-head
of the communications and information technology fund of MMC Capital (a subsidiary
of Marsh & McLennan Companies Inc.), managing director and head of U.S. merchant
banking operations for CIBC Capital Partners, senior vice president of First
City Capital Corporation, and an attorney with Torys. He is a member of the
board of trustees of the League for the Hard of Hearing and was a member of
the board of directors of Equator Technologies, GoAmerica, and Xanoptix, among
others. He also directed the 1973 short film, "Life Times Nine," which was
nominated for an Academy Award. He earned his bachelor's degree from Innis
College, University of Toronto; a law degree from the Faculty of Law, University
of Toronto; and a master's in business administration (Baker Scholar) from
the Harvard University Graduate School of Business Administration.
Helen Mayberg, M.D., Professor, Emory University
Dr. Mayberg is a professor of psychiatry and neurology at the Emory University
School of Medicine. She also holds adjunct appointments at the University of
Toronto. She is well known for functional imaging studies of the various states
of mood and emotions in health and disease. Her recent study using deep brain
stimulation to successfully treat severe depression that did not respond to
other therapies generated international interest. Most recently Dr. Mayberg
directed the neuropsychiatry program at the Rotman Research Institute, University
of Toronto, and mapped depression in the brain. She is a member of the editorial
boards of the journals NeuroInformatics, Depression & Anxiety, NeuroImage,
and Human Brain Mapping. She received her undergraduate degree from the University
of California, Los Angeles and her medical degree from the University of Southern
California, School of Medicine.
Laura Ment, M.D., Yale School of Medicine
Dr. Ment is a professor of pediatrics and neurology at Yale School of Medicine
and has taught there since 1979. She studies the influence of pre-term birth
on the developing brain. Her research interests include bleeding in the brain,
a somewhat common occurrence among pre-term babies, and its significant effect
on neurodevelopment, neurogenetic disorders, and neonatal and fetal stroke.
She is using functional MRI to study and monitor changes in cerebral activity
in infants as they develop and mature, with long-term hopes of being able to
detect functional differences in the cerebral development of term and very
low birth weight preterm infants. Dr. Ment is a noted author and speaker, has
received numerous grants and teaching awards, and is the Councilor from the
East for the Child Neurology Society. She received her bachelorís degree from
Brown University and her medical degree from Tufts University.
Additionally, Secretary Leavitt announced that Patrick Pullicino, M.D., Ph.D.,
would serve an additional year on the Council. Dr. Pullicino is professor and
chairman of neurosciences at the University of Medicine and Dentistry of New
Jersey, Newark. His research interests include neuroradiology, stroke, and cerebral
effects of cardiac disease. He received his medical degree with distinction from
the University of Malta and his neurology training in London, England, and at
the University of Rochester, New York.
The NINDS is the nationís primary funder of research on the brain and nervous
system. More information about the NINDS and its mission is available at www.ninds.nih.gov.
The National Institutes of Health (NIH) — The Nation's Medical Research
Agency — includes 27 Institutes and Centers and is a component of
the U. S. Department of Health and Human Services. It is the primary Federal
agency for conducting and supporting basic, clinical, and translational medical
research, and investigates the causes, treatments, and cures for both common
and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.